Hayadan > Tune Therapeutics
Tune Therapeutics
- Avi Blizovsky
- No comments
New systems use CRISPR's navigational capabilities to silence or activate genes without cutting DNA. First clinical trials in FSHD and hepatitis B are testing whether epigenetic modification can be targeted, safe